Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Initial phase III results of the first trial in newly diagnosed multiple myeloma
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France
Initial phase III results of the first trial in newly diagnosed multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France )
10 Dec 2013
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and...
Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013
Chimeric antigen receptor produces complete responses and long-term persistence...
Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Study of the efficacy and safety of siltuximab, an anti-interleukin-6...
Dr Raymond Wong - Chinese University of Hong Kong
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )
8 Dec 2013
In vitro and in vivo assessment of anfibatide, a novel glycoprotein ib...
Dr Neyu Ni - University of Toronto, Canada
In vitro and in vivo assessment of anfibatide, a novel glycoprotein ib antagonist ( Dr Neyu Ni - University of Toronto, Canada )
8 Dec 2013
Results from the randomised phase III Children’s Oncology Group (COG) trial...
Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013
Final stage II results of the CLL11 trial
Dr Valentin Goede - University of Cologne, Germany
Final stage II results of the CLL11 trial ( Dr Valentin Goede - University of Cologne, Germany )
8 Dec 2013
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
7 Dec 2013
Immunotherapy in metastatic kidney cancer
Dr Thomas Schwabb - Roswell Park Cancer Institute, Buffalo, USA
Immunotherapy in metastatic kidney cancer ( Dr Thomas Schwabb - Roswell Park Cancer Institute, Buffalo, USA )
5 Dec 2013
Toxicity complications from chemotherapy in lung cancer treatment
Dr G.S. Bhattacharyya - FORTIS Hospitals, Kolkata, India
Toxicity complications from chemotherapy in lung cancer treatment ( Dr G.S. Bhattacharyya - FORTIS Hospitals, Kolkata, India )
5 Dec 2013
Multidisciplinary in cancer care in India
Dr Harit Chaturavadi - Max Institute of Oncology, New Delhi, India
Multidisciplinary in cancer care in India ( Dr Harit Chaturavadi - Max Institute of Oncology, New Delhi, India )
5 Dec 2013
Goals of 1st Indian Cancer Congress
Dr Ashok K. Vaid - Medanta The Medicity, Haryana, India
Goals of 1st Indian Cancer Congress ( Dr Ashok K. Vaid - Medanta The Medicity, Haryana, India )
5 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation